PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 5, 2009, Pages

  Yang, Jing ^a   Lane, Pascale H ^a   Pollock, Jennifer S ^b   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Calphostin C; Chelerythrine; Diabetes mellitus; G 6976; Rottlerin

Indexed keywords

CALPHOSTIN C; CHELERYTHRINE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; ROTTLERIN; SUPEROXIDE; TEMPOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY MEDULLA; LIMB; MALE; MEMBRANE BINDING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; UPREGULATION; WESTERN BLOTTING;

EID: 70350736105     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00314.2009     Document Type: Article

References (61)

1. Aristimuño PC, Good DW. PKC isoforms in rat medullary thick ascending limb: selective activation of the δ isoform by PGE2. Am J Physiol Renal Physiol 272: F624-F631, 1997. (Pubitemid 27382211)
2. Cosentino F, Eto M, De PP, Van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli GC, Joch H, Volpe M, Luscher TF. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107: 1017-1023, 2003. (Pubitemid 36258726)
3. Craven PA, Davidson CM, DeRubertis FR. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39: 667-674, 1990. (Pubitemid 20218964)
4. DeRubertis FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes: mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43: 1-8, 1994. (Pubitemid 24010522)
5. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21: 1736-1742, 1998. (Pubitemid 28449817)
6. Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med 28: 1349-1361, 2000. (Pubitemid 30621479)
7. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98, 1994. (Pubitemid 24179919)
8. phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction. Am J Physiol Heart Circ Physiol 296: H1048-H1057, 2009.
9. Ha H, Kim KH. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res Clin Pract 45: 147-151, 1999. (Pubitemid 29457762)
10. Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol 14: S246-S249, 2003. (Pubitemid 36903934)
11. Ha H, Yu MR, Choi YJ, Lee HB. Activation of protein kinase C-δ and C-ε by oxidative stress in early diabetic rat kidney. Am J Kidney Dis 38: S204-S207, 2001. (Pubitemid 32927645)
12. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999, 1990.
13. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RAK, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Förstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: e14-e22, 2001.
14. Hua H, Goldberg HJ, Fantus IG, Whiteside CI. High glucose-enhanced mesangial cell extracellular signal-regulated protein kinase activation and alpha1(IV) collagen expression in response to endothelin-1: role of specific protein kinase C isozymes. Diabetes 50: 2376-2383, 2001. (Pubitemid 33641925)
15. 2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells. J Biol Chem 278: 33951-33962, 2003.
16. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
17. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14: S227-S232, 2003. (Pubitemid 36903930)
18. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol Endocrinol Metab 267: E369-E379, 1994. (Pubitemid 2154692)
19. Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller H. Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int 56: 1737-1750, 1999. (Pubitemid 29518174)
20. Keenan C, Goode N, Pears C. Isoform specificity of activators and inhibitors of protein kinase C γ and δ. FEBS Lett 415: 101-108, 1997. (Pubitemid 27402058)
21. Kelly DJ, Chanty A, Gow RM, Zhang Y, Gilbert RE. Protein kinase Cβ inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J Am Soc Nephrol 16: 1654-1660, 2005. (Pubitemid 41716471)
22. phox by protein kinase C-β activation is required for oxidative stress in diabetic nephropathy. Diabetes 52: 2603-2614, 2003.
23. Kohda Y, Gemba M. Cephaloridine induces translocation of protein kinase C δ into mitochondria and enhances mitochondrial generation of free radicals in the kidney cortex of rats causing renal dysfunction. J Pharmacol Sci 98: 49-57, 2005. (Pubitemid 40806127)
24. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKCβ inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14: 439-447, 2000. (Pubitemid 30143162)
25. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100: 115-126, 1997. (Pubitemid 27311249)
26. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14: S241-S245, 2003. (Pubitemid 36903933)
27. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 65: 1170-1179, 2004. (Pubitemid 38406955)
28. Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol Renal Physiol 282: F1111-F1119, 2002. (Pubitemid 34654477)
29. Lin WW, Chen BC. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages. Br J Pharmacol 125: 1601-1609, 1998.
30. Luo JD, Wang YY, Fu WL, Wu J, Chen AF. Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 110: 2484-2493, 2004. (Pubitemid 39407357)
31. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 268: 9194-9197, 1993. (Pubitemid 23145960)
32. Matassa AA, Kalkofen RL, Carpenter L, Biden TJ, Reyland ME. Inhibition of PKCα induces a PKCδ-dependent apoptotic program in salivary epithelial cells. Cell Death Differ 10: 269-277, 2003. (Pubitemid 36582365)
33. Mochly-Rosen D, Henrich CJ, Cheever L, Khaner H, Simpson PC. A protein kinase C isozyme is translocated to cytoskeletal elements on activation. Cell Regul 1: 693-706, 1990.
34. Mochly-Rosen D, Gordon AS. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 12: 35-42, 1998. (Pubitemid 28060269)
35. Mori T, Cowley AW Jr. Renal oxidative stress in medullary thick ascending limbs produced by elevated NaCl and glucose. Hypertension 43: 341-346, 2004. (Pubitemid 38174136)
36. Murakami M, Horowitz A, Tang S, Ware JA, Simons M. Protein kinase C (PKC) δ regulates PKCα activity in a syndecan-4-dependent manner. J Biol Chem 277: 20367-20371, 2002. (Pubitemid 34967331)
37. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000. (Pubitemid 30212409)
38. Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cβ-null mice. Diabetes 55: 3112-3120, 2006. (Pubitemid 44923650)
39. Osicka TM, Yu Y, Lee V, Panagiotopoulos S, Kemp BE, Jerums G. Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery. Clin Sci 100: 249-257, 2001. (Pubitemid 32215995)
40. Patskan GJ, Baxter CS. Specific stimulation of histone H2B and H4 phosphorylation in mouse lymphocytes by 12-O-tetradecanoylphorbol 13-acetate. J Biol Chem 260: 12899-12903, 1985. (Pubitemid 16209748)
41. Pfleiderer S, Zimmerhackl LB, Kinne R, Manz F, Schuler G, Brandis M. Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein. Clin Invest 71: 972-977, 1993. (Pubitemid 2010296)
42. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh St, Lee HB. Role of reactive oxygen species in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16: 667-675, 2005. (Pubitemid 41725103)
43. Saraiva L, Fresco P, Pinto E, Gonçalves J. Isoform-selectivity of PKC inhibitors acting at the regulatory and catalytic domain of mammalian PKC-α, -βI, -δ, -η and -ζ. J Enzyme Inhib Med Chem 18: 475-483, 2003. (Pubitemid 37493382)
44. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity - upstream mediators. Circ Res 91: 406-413, 2002. (Pubitemid 35034208)
45. Shen GX. Selective protein kinase C inhibitors and their applications. Curr Drug Targets Cardiovasc Haematol Disord 3: 301-307, 2003. (Pubitemid 37540861)
46. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol Endocrinol Metab 265: E783-E793, 1993. (Pubitemid 2015667)
47. Shirai Y, Sakai N, Saito N. Subspecies-specific targeting mechanism of protein kinase C. Jpn J Pharmacol 78: 411-417, 1998. (Pubitemid 29052062)
48. Silva G, Beierwaltes WH, Garvin JL. Extracellular ATP stimulates NO production in rat thick ascending limb. Hypertension 47: 563-567, 2006. (Pubitemid 43843876)
49. Silva GB, Garvin JL. Angiotensin II-dependent hypertension increases Na transport-related oxygen consumption by the thick ascending limb. Hypertension 52: 1091-1098, 2008.
50. Silva GB, Ortiz PA, Hong NJ, Garvin JL. Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C. Hypertension 48: 467-472, 2006.
51. Soltoff SP. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cδ tyrosine phosphorylation. J Biol Chem 276: 37986-37992, 2001. (Pubitemid 37384049)
52. Soltoff SP. Rottlerin: an inappropriate and ineffective inhibitor of PKCδ. Trends Pharmacol Sci 28: 453-458, 2007.
53. Studer RK, Craven PA, DeRubertis FR. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46: 918-925, 1997.
54. Tanaka M, Sagawa S, Hoshi Ji Shimoma F, Matsuda I, Sakoda K, Sasase T, Shindo M, Inaba T. Synthesis of anilino-monoindolylmaleimides as potent and selective PKCβ inhibitors. Bioorg Med Chem Lett 14: 5171-5174, 2004. (Pubitemid 39233388)
55. Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12: 177-186, 2005. (Pubitemid 40489000)
56. +-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46: 124-131, 2003.
57. - and is diminished by a high-salt diet. Am J Physiol Renal Physiol 287: F224-F230, 2004.
58. Wen HC, Huang WC, Ali A, Woodgett JR, Lin WW. Negative regulation of phosphatidylinositol 3-kinase and Akt signalling pathway by PKC. Cell Signal 15: 37-45, 2003. (Pubitemid 35223627)
59. Whiteside CI, Dlugosz JA. Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol 282: F975-F980, 2002. (Pubitemid 34654462)
60. Zimmerhackl LB, Pfleiderer S, Kinne R, Manz F, Schuler G, Brandis M. Tamm-Horsfall-Protein excretion as a marker of ascending limb transport indicates early renal tubular damage in diabetes mellitus type I. J Diabet Complications 5: 112-114, 1991.
61. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 37: 547-553, 2001. (Pubitemid 32199026)